In Arrhythmia Solet Tablet works by blocking abnormal electrical signals in the heart. This helps control the uneven beating of your heart and helps it to beat normally. It is normally only given by injection in a hospital when a fast response is needed or when tablets have not worked or cannot be given. This medicine thus prevents serious health problems that can sometimes be fatal and reduces your risk of death.
It is unsafe to consume alcohol with Solet Tablet.
Solet Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Solet Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Solet Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Solet Tablet should be used with caution in patients with kidney disease. Dose adjustment of Solet Tablet may be needed. Please consult your doctor. Use of Solet Tablet is not recommended in patients with serious kidney disease.
Solet Tablet is safe to use in patients with liver disease. No dose adjustment of Solet Tablet is recommended.
If you miss a dose of Solet Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Cipla Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Glaxo SmithKline Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)